PMID- 30477246 OWN - NLM STAT- MEDLINE DCOM- 20190308 LR - 20200225 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 19 IP - 12 DP - 2018 Nov 24 TI - Wnt/beta-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson's Disease. LID - 10.3390/ijms19123743 [doi] LID - 3743 AB - Wingless-type mouse mammary tumor virus (MMTV) integration site (Wnt) signaling is one of the most critical pathways in developing and adult tissues. In the brain, Wnt signaling contributes to different neurodevelopmental aspects ranging from differentiation to axonal extension, synapse formation, neurogenesis, and neuroprotection. Canonical Wnt signaling is mediated mainly by the multifunctional beta-catenin protein which is a potent co-activator of transcription factors such as lymphoid enhancer factor (LEF) and T-cell factor (TCF). Accumulating evidence points to dysregulation of Wnt/beta-catenin signaling in major neurodegenerative disorders. This review highlights a Wnt/beta-catenin/glial connection in Parkinson's disease (PD), the most common movement disorder characterized by the selective death of midbrain dopaminergic (mDAergic) neuronal cell bodies in the subtantia nigra pars compacta (SNpc) and gliosis. Major findings of the last decade document that Wnt/beta-catenin signaling in partnership with glial cells is critically involved in each step and at every level in the regulation of nigrostriatal DAergic neuronal health, protection, and regeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD, focusing on Wnt/beta-catenin signaling to boost a full neurorestorative program in PD. FAU - Marchetti, Bianca AU - Marchetti B AUID- ORCID: 0000-0002-9287-8448 AD - Department of Biomedical and Biotechnological Sciences (BIOMETEC), Pharmacology Section, Medical School, University of Catania, Via Santa Sofia 97, 95123 Catania, Italy. biancamarchetti@libero.it. AD - OASI Research Institute-IRCCS, Section of Neuropharmacology, Via Conte Ruggero 73, 94018 Troina (EN), Italy. biancamarchetti@libero.it. LA - eng PT - Journal Article PT - Review DEP - 20181124 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (CTNNB1 protein, mouse) RN - 0 (Hepatocyte Nuclear Factor 1-alpha) RN - 0 (Hnf1a protein, mouse) RN - 0 (Lef1 protein, mouse) RN - 0 (Lymphoid Enhancer-Binding Factor 1) RN - 0 (Wnt Proteins) RN - 0 (beta Catenin) SB - IM MH - Animals MH - Cell Survival MH - Cell- and Tissue-Based Therapy/methods MH - Disease Models, Animal MH - Dopaminergic Neurons/*metabolism/pathology MH - Gene Expression Regulation MH - Hepatocyte Nuclear Factor 1-alpha/genetics/metabolism MH - Humans MH - Lymphoid Enhancer-Binding Factor 1/genetics/metabolism MH - Mice MH - Neural Stem Cells/metabolism/pathology MH - Neurogenesis/*genetics MH - Neuroglia/metabolism/pathology MH - Parkinsonian Disorders/*genetics/metabolism/pathology/therapy MH - Pars Compacta/metabolism/pathology MH - Regeneration/*genetics MH - Signal Transduction/*genetics MH - Wnt Proteins/*genetics/metabolism MH - beta Catenin/*genetics/metabolism PMC - PMC6321180 OTO - NOTNLM OT - Parkinson's disease OT - Wnt/beta-catenin signaling OT - cell death OT - dopaminergic neurons OT - glia-neuron cross-talk OT - neurodegeneration OT - neuroprotection OT - neurorepair COIS- The author declares no conflicts of interest. EDAT- 2018/11/28 06:00 MHDA- 2019/03/09 06:00 PMCR- 2018/12/01 CRDT- 2018/11/28 06:00 PHST- 2018/10/17 00:00 [received] PHST- 2018/11/12 00:00 [revised] PHST- 2018/11/17 00:00 [accepted] PHST- 2018/11/28 06:00 [entrez] PHST- 2018/11/28 06:00 [pubmed] PHST- 2019/03/09 06:00 [medline] PHST- 2018/12/01 00:00 [pmc-release] AID - ijms19123743 [pii] AID - ijms-19-03743 [pii] AID - 10.3390/ijms19123743 [doi] PST - epublish SO - Int J Mol Sci. 2018 Nov 24;19(12):3743. doi: 10.3390/ijms19123743.